The '2-week wait' rule for referrals for suspected urological cancers - Urgent need for refinement of criteria

Annals of the Royal College of Surgeons of England

Volumn 90, Issue 6, 2008, Pages 517-522

  Hawary, Amr M ^a   Warburton, Hazel E ^a   Brough, Richard J ^a   Collins, Gerald N ^a   Brown, Stephen C ^a   O'Reilly, Patrick H ^a   Adeyoju, Adebanji A B ^a  

^a STEPPING HILL HOSPITAL   (United Kingdom)

Author keywords

'2 week wait' rule; Cancer incidence; Cancer targets; Macroscopic haematuria; PSA; Testicular mass

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER INCIDENCE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEMATURIA; HUMAN; INTESTINE CANCER; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PENIS CANCER; PRACTICE GUIDELINE; PROSTATE CANCER; PROSTATECTOMY; SCROTAL SWELLING; TESTIS CANCER; URINARY TRACT CANCER; VAGINA CANCER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ENGLAND; FEMALE; HEMATURIA; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSTATE-SPECIFIC ANTIGEN; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; TESTICULAR NEOPLASMS; UROLOGIC NEOPLASMS; WAITING LISTS;

EID: 52649104473     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588408X301082     Document Type: Article

References (14)

1. NHS Executive. The New NHS modern and dependable; a national framework for assessing performance. London: Department of Health, 1998.
2. Department of Health. The NHS cancer plan. London: Department of Health, 2000.
3. Jones R, Rubin G, Hungin P. Is the two week rule for cancer referrals working? BMJ 2001; 322: 1555-6.
4. National Institute for Health and Clinical Excellence. Referral Guidelines for Suspected Cancer. (Clinical Guideline 27. London: NICE, 2005.
5. European Association of Urology. Guidelines on prostate cancer. Update March 2007.
6. Klotz LH. Active surveillance with selective delayed intervention using PSA doubling time for good risk prostate cancer. Eur Urol 2005; 47: 16-21.
7. Hardie C, Parker C, Norman A, Eeles R, Horwich A, Huddart R et al. Early outcomes of active surveillance for localized prostate cancer. BJU Int 2005; 95: 956-60.
8. Avon Health Authority. December 2001.
9. Allen D, Popert R, O'Brien T. The two-week-wait cancer initiative in urology: useful modernization? J R Soc Med 2004; 97: 279-81.
10. Fentiman IS, Tirelli U, Monfardini S, Schneider M, Festen J, Cognetti F et al. Cancer in the elderly; why so badly treated? Lancet 1990; 335: 1020-2.
11. The Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. BJU Int 1997; 79: 235-46.
12. Albertson PC, Hanley JA, Fine J. 20-Year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005; 293: 2095-101.
13. Khawaja AR, Allan SM. Audit of referral practice to fast-access breast clinic before the guaranteed two-week wait. Ann R Coll Surg Engl 2001; 83: 58-60.
14. Williams RW, Hughes W, Felmingham S, Irvine GH. An audit of two week wait referrals for head and neck cancer. Ann R Coll Surg Engl 2002; 84: 304-6.